(BYND) Beyond Meat - Overview
Sector: Consumer DefensiveIndustry: Packaged Foods | Exchange NASDAQ (USA) | Currency USD | Market Cap: 295m | Total Return -80.8% in 12m
Stock: Plant-Based Meat, Beef Alternative, Pork Alternative, Poultry Alternative
Total Rating 12
Risk 35
Buy Signal -1.75
| Risk 5d forecast | |
|---|---|
| Volatility | 85.0% |
| Relative Tail Risk | -20.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.07 |
| Alpha | -103.27 |
| Character TTM | |
|---|---|
| Beta | 2.185 |
| Beta Downside | 1.752 |
| Drawdowns 3y | |
|---|---|
| Max DD | 97.06% |
| CAGR/Max DD | -0.68 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: BYND Beyond Meat March 17, 2026
Beyond Meat, Inc. (BYND) produces and sells plant-based meat substitutes globally. The companys products replicate beef, pork, and poultry. This business model operates within the packaged foods sector, which is characterized by extensive distribution networks.
Distribution channels include retail (groceries, mass merchandisers) and foodservice (restaurants, schools). Founded in 2008, the company changed its name from Savage River, Inc. in 2018. Further research on ValueRay can provide deeper insights into its financial performance.
Headlines to watch out for
- Retail channel sales growth boosts top-line revenue
- Foodservice partnerships expand market penetration
- Raw material costs impact gross margins
- Consumer adoption of plant-based diets drives demand
- Competition from traditional meat and other plant-based brands intensifies
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -237.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.24 > 0.02 and ΔFCF/TA -8.68 > 1.0 |
| NWC/Revenue: 77.43% < 20% (prev 65.17%; Δ 12.26% < -1%) |
| CFO/TA -0.21 > 3% & CFO -127.1m > Net Income -237.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.5m) vs 12m ago 17.51% < -2% |
| Gross Margin: 9.62% > 18% (prev 0.06%; Δ 956.5% > 0.5%) |
| Asset Turnover: 44.96% > 50% (prev 46.68%; Δ -1.72% > 0%) |
| Interest Coverage Ratio: -15.51 > 6 (EBITDA TTM -196.3m / Interest Expense TTM 14.5m) |
Altman Z'' -8.77
| A: 0.38 (Total Current Assets 288.6m - Total Current Liabilities 63.6m) / Total Assets 599.7m |
| B: -2.39 (Retained Earnings -1.43b / Total Assets 599.7m) |
| C: -0.35 (EBIT TTM -225.2m / Avg Total Assets 646.3m) |
| D: -1.04 (Book Value of Equity -1.44b / Total Liabilities 1.38b) |
| Altman-Z'' Score: -8.77 = D |
Beneish M -3.88
| DSRI: 0.90 (Receivables 27.9m/34.7m, Revenue 290.6m/323.5m) |
| GMI: 0.61 (GM 9.62% / 5.92%) |
| AQI: 0.73 (AQ_t 0.09 / AQ_t-1 0.12) |
| SGI: 0.90 (Revenue 290.6m / 323.5m) |
| TATA: -0.18 (NI -237.7m - CFO -127.1m) / TA 599.7m) |
| Beneish M-Score: -3.88 (Cap -4..+1) = AAA |
What is the price of BYND shares?
As of March 29, 2026, the stock is trading at USD 0.64 with a total of 18,862,073 shares traded.
Over the past week, the price has changed by -8.41%, over one month by -32.62%, over three months by -26.09% and over the past year by -80.75%.
Over the past week, the price has changed by -8.41%, over one month by -32.62%, over three months by -26.09% and over the past year by -80.75%.
Is BYND a buy, sell or hold?
Beyond Meat has received a consensus analysts rating of 2.20.
Therefor, it is recommend to sell BYND.
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 2
- StrongSell: 3
What are the forecasts/targets for the BYND price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1.6 | 151.6% |
| Analysts Target Price | 1.6 | 151.6% |
BYND Fundamental Data Overview March 28, 2026
P/E Forward = 5000.0
P/S = 1.0146
P/B = 59.3234
P/EG = 40.7473
Revenue TTM = 290.6m USD
EBIT TTM = -225.2m USD
EBITDA TTM = -196.3m USD
Long Term Debt = 1.24b USD (from longTermDebt, last quarter)
Short Term Debt = 6.31m USD (from shortTermDebt, last quarter)
Debt = 1.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.19b USD (from netDebt column, last quarter)
Enterprise Value = 1.49b USD (294.8m + Debt 1.31b - CCE 117.3m)
Interest Coverage Ratio = -15.51 (Ebit TTM -225.2m / Interest Expense TTM 14.5m)
EV/FCF = -10.42x (Enterprise Value 1.49b / FCF TTM -142.9m)
FCF Yield = -9.60% (FCF TTM -142.9m / Enterprise Value 1.49b)
FCF Margin = -49.18% (FCF TTM -142.9m / Revenue TTM 290.6m)
Net Margin = -81.81% (Net Income TTM -237.7m / Revenue TTM 290.6m)
Gross Margin = 9.62% ((Revenue TTM 290.6m - Cost of Revenue TTM 262.6m) / Revenue TTM)
Gross Margin QoQ = 10.30% (prev 13.73%)
Tobins Q-Ratio = 2.48 (Enterprise Value 1.49b / Total Assets 599.7m)
Interest Expense / Debt = 0.80% (Interest Expense 10.5m / Debt 1.31b)
Taxrate = 21.0% (US default 21%)
NOPAT = -177.9m (EBIT -225.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.54 (Total Current Assets 288.6m / Total Current Liabilities 63.6m)
Debt / Equity = -1.67 (negative equity) (Debt 1.31b / totalStockholderEquity, last quarter -784.1m)
Debt / EBITDA = -6.08 (negative EBITDA) (Net Debt 1.19b / EBITDA -196.3m)
Debt / FCF = -8.36 (negative FCF - burning cash) (Net Debt 1.19b / FCF TTM -142.9m)
Total Stockholder Equity = -678.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -36.78% (Net Income -237.7m / Total Assets 599.7m)
RoE = 35.06% (negative equity) (Net Income TTM -237.7m / Total Stockholder Equity -678.0m)
RoCE = -40.29% (EBIT -225.2m / Capital Employed (Equity -678.0m + L.T.Debt 1.24b))
RoIC = -35.53% (negative operating profit) (NOPAT -177.9m / Invested Capital 500.8m)
WACC = 3.02% (E(294.8m)/V(1.61b) * Re(13.67%) + D(1.31b)/V(1.61b) * Rd(0.80%) * (1-Tc(0.21)))
Discount Rate = 13.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.83%
[DCF] Fair Price = unknown (Cash Flow -142.9m)
EPS Correlation: 92.22 | EPS CAGR: 113.6% | SUE: 1.61 | # QB: 1
Revenue Correlation: -71.01 | Revenue CAGR: -9.16% | SUE: 0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=-0.48 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+4 | Growth EPS=+55.5% | Growth Revenue=-1.1%
P/S = 1.0146
P/B = 59.3234
P/EG = 40.7473
Revenue TTM = 290.6m USD
EBIT TTM = -225.2m USD
EBITDA TTM = -196.3m USD
Long Term Debt = 1.24b USD (from longTermDebt, last quarter)
Short Term Debt = 6.31m USD (from shortTermDebt, last quarter)
Debt = 1.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.19b USD (from netDebt column, last quarter)
Enterprise Value = 1.49b USD (294.8m + Debt 1.31b - CCE 117.3m)
Interest Coverage Ratio = -15.51 (Ebit TTM -225.2m / Interest Expense TTM 14.5m)
EV/FCF = -10.42x (Enterprise Value 1.49b / FCF TTM -142.9m)
FCF Yield = -9.60% (FCF TTM -142.9m / Enterprise Value 1.49b)
FCF Margin = -49.18% (FCF TTM -142.9m / Revenue TTM 290.6m)
Net Margin = -81.81% (Net Income TTM -237.7m / Revenue TTM 290.6m)
Gross Margin = 9.62% ((Revenue TTM 290.6m - Cost of Revenue TTM 262.6m) / Revenue TTM)
Gross Margin QoQ = 10.30% (prev 13.73%)
Tobins Q-Ratio = 2.48 (Enterprise Value 1.49b / Total Assets 599.7m)
Interest Expense / Debt = 0.80% (Interest Expense 10.5m / Debt 1.31b)
Taxrate = 21.0% (US default 21%)
NOPAT = -177.9m (EBIT -225.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.54 (Total Current Assets 288.6m / Total Current Liabilities 63.6m)
Debt / Equity = -1.67 (negative equity) (Debt 1.31b / totalStockholderEquity, last quarter -784.1m)
Debt / EBITDA = -6.08 (negative EBITDA) (Net Debt 1.19b / EBITDA -196.3m)
Debt / FCF = -8.36 (negative FCF - burning cash) (Net Debt 1.19b / FCF TTM -142.9m)
Total Stockholder Equity = -678.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -36.78% (Net Income -237.7m / Total Assets 599.7m)
RoE = 35.06% (negative equity) (Net Income TTM -237.7m / Total Stockholder Equity -678.0m)
RoCE = -40.29% (EBIT -225.2m / Capital Employed (Equity -678.0m + L.T.Debt 1.24b))
RoIC = -35.53% (negative operating profit) (NOPAT -177.9m / Invested Capital 500.8m)
WACC = 3.02% (E(294.8m)/V(1.61b) * Re(13.67%) + D(1.31b)/V(1.61b) * Rd(0.80%) * (1-Tc(0.21)))
Discount Rate = 13.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.83%
[DCF] Fair Price = unknown (Cash Flow -142.9m)
EPS Correlation: 92.22 | EPS CAGR: 113.6% | SUE: 1.61 | # QB: 1
Revenue Correlation: -71.01 | Revenue CAGR: -9.16% | SUE: 0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=-0.48 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+4 | Growth EPS=+55.5% | Growth Revenue=-1.1%